{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:59:05Z","timestamp":1783947545795,"version":"3.55.0"},"reference-count":215,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.addr.2022.114133","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T18:31:35Z","timestamp":1643481095000},"page":"114133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Women\u2019s preferences and acceptance for different drug delivery routes and products"],"prefix":"10.1016","volume":"182","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9311-8355","authenticated-orcid":false,"given":"Rita","family":"Palmeira-de-Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Sofia","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5291-212X","authenticated-orcid":false,"given":"Joana","family":"Rolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Tom\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Palmeira-de-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9rgio","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8608-0248","authenticated-orcid":false,"given":"Jos\u00e9","family":"Martinez-de-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2022.114133_b0005","first-page":"511","article-title":"Preferences for health interventions: improving uptake","volume":"10","author":"Ostermann","year":"2017","journal-title":"Adher. Eff. Pat."},{"key":"10.1016\/j.addr.2022.114133_b0010","doi-asserted-by":"crossref","DOI":"10.1186\/s13561-017-0162-6","article-title":"Discrete-choice modelling of patient preferences for modes of drug administration","volume":"7","author":"Tetteh","year":"2017","journal-title":"Health Econ. Rev."},{"key":"10.1016\/j.addr.2022.114133_b0015","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jval.2019.04.1930","article-title":"What is next for patient preferences in health technology assessment? A systematic review of the challenges","volume":"22","author":"Huls","year":"2019","journal-title":"Value Heal."},{"key":"10.1016\/j.addr.2022.114133_b0020","doi-asserted-by":"crossref","unstructured":"C. Dehlendorf, E. Fox, L. Sobel, S. Borrero, Patient-Centered Contraceptive Counseling: Evidence to Inform Practice, Curr. Obstet. Gynecol. Reports 2016 51. 5 (2016) 55\u201363. Doi: 10.1007\/S13669-016-0139-1.","DOI":"10.1007\/s13669-016-0139-1"},{"key":"10.1016\/j.addr.2022.114133_b0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/13697137.2011.647840","article-title":"Vaginal Health: insights, views & attitudes (VIVA) - results from an international survey","volume":"15","author":"Nappi","year":"2012","journal-title":"Climacteric."},{"key":"10.1016\/j.addr.2022.114133_b0030","first-page":"23","article-title":"Management of vaginal atrophy: implications from the REVIVE survey","volume":"8","author":"Wysocki","year":"2014","journal-title":"Clin. Med. Insights. Reprod. Heal."},{"key":"10.1016\/j.addr.2022.114133_b0035","first-page":"259","article-title":"Women\u2019s experiences, preferences and perceptions regarding vaginal products: Results from a cross-sectional web-based survey in Portugal","volume":"20","author":"Palmeira-de-Oliveira","year":"2015","journal-title":"Eur. J. Contracept. Reprod. Heal. Care."},{"key":"10.1016\/j.addr.2022.114133_b0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1208\/s12248-009-9082-7","article-title":"Vaginal drug delivery systems for HIV prevention","volume":"11","author":"Rohan","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2022.114133_b0045","article-title":"Developing multipurpose reproductive health technologies: an integrated strategy","volume":"2013","author":"Harrison","year":"2013","journal-title":"AIDS Res. Treat."},{"key":"10.1016\/j.addr.2022.114133_b0050","doi-asserted-by":"crossref","unstructured":"J. das Neves, F. Notario-P\u00e9rez, B. Sarmento, Women-specific routes of administration for drugs: A critical overview, Adv. Drug Deliv. Rev. 176 (2021) 113865. Doi: 10.1016\/J.ADDR.2021.113865.","DOI":"10.1016\/j.addr.2021.113865"},{"key":"10.1016\/j.addr.2022.114133_b0055","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.addr.2015.02.004","article-title":"Acceptability and preferences for vaginal dosage forms intended for prevention of HIV or HIV and pregnancy","volume":"92","author":"Woodsong","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114133_b0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1089\/152460901300039502","article-title":"Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going?","volume":"10","author":"Elias","year":"2001","journal-title":"J. Womens Heal. Gend Based Med."},{"key":"10.1016\/j.addr.2022.114133_b0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0010-7824(98)00106-1","article-title":"Women\u2019s preferences for vaginal antimicrobial contraceptives. IV. Attributes of a formulation that would protect from STD\/AIDS","volume":"58","author":"Hardy","year":"1998","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.0022-4537.2005.00393.x","article-title":"Critical issues in contraceptive and STI acceptability research","volume":"61","author":"Severy","year":"2005","journal-title":"J. Soc. Issues."},{"key":"10.1016\/j.addr.2022.114133_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89284-3","article-title":"Design aspects of vaginal applicators that influence acceptance among target users","volume":"11","author":"Bakke","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2022.114133_b0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0091-7435(77)90005-6","article-title":"Acceptability of fertility regulating methods: designing technology to fit people","volume":"6","author":"Marshall","year":"1977","journal-title":"Prev. Med. (Baltim)"},{"key":"10.1016\/j.addr.2022.114133_b0085","doi-asserted-by":"crossref","unstructured":"C. Coggins, C.J. Elias, R. Atisook, M.T. Bassett, V. Ettiegnene-Traore, P.D. Ghys, L. Jenkins-Woelk, E. Thongkrajai, N.L. VanDevanter, Women\u2019s preferences regarding the formulation of over-the-counter vaginal spermicides, AIDS. 12 (1998) 1389\u20131391. http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9708420.","DOI":"10.1097\/00002030-199811000-00022"},{"key":"10.1016\/j.addr.2022.114133_b0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.socscimed.2004.05.011","article-title":"Microbicide acceptability research: current approaches and future directions","volume":"60","author":"Mantell","year":"2005","journal-title":"Soc Sci Med."},{"key":"10.1016\/j.addr.2022.114133_b0095","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/13625187.2011.636088","article-title":"Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study","volume":"17","author":"Short","year":"2012","journal-title":"Eur. J. Contracept. Reprod. Heal. Care Off. J. Eur. Soc. Contracept."},{"key":"10.1016\/j.addr.2022.114133_b0100","doi-asserted-by":"crossref","unstructured":"K. Morrow, R. Rosen, L. Richter, A. Emans, A. Forbes, J. Day, N. Morar, L. Maslankowski, A.T. Profy, C. Kelly, S.S.A. Karim, K.H. Mayer, The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial, J Womens Heal. 12 (2003) 655\u2013666. Doi: 10.1089\/154099903322404302.","DOI":"10.1089\/154099903322404302"},{"key":"10.1016\/j.addr.2022.114133_b0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0010-7824(02)00514-0","article-title":"The combined contraceptive vaginal ring, NuvaRing\u00ae: An international study of user acceptability","volume":"67","author":"Nov\u00e1k","year":"2003","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0110","first-page":"73","article-title":"Cultural differences in acceptability of a vaginal microbicide: a comparison between potential users from Nashville, Tennessee, USA, and Kafue and Mumbwa, Zambia, HIV","volume":"4","author":"Rice","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.addr.2022.114133_b0115","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1007\/s10461-013-0652-4","article-title":"\u201cSet it and Forget it\u201d: Women\u2019s Perceptions and Opinions of Long-Acting Topical Vaginal Gels","volume":"18","author":"van den Berg","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.addr.2022.114133_b0120","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/17512433.2020.1805314","article-title":"Guiding principles for the use of knowledge bases and real-world data in clinical decision support systems: report by an international expert workshop at Karolinska Institutet","volume":"13","author":"Hoffmann","year":"2020","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2022.114133_b0125","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/PPA.S38984","article-title":"Factors involved in patient choice of oral or vaginal treatment for vulvovaginal candidiasis","volume":"8","author":"Sobel","year":"2013","journal-title":"Patient Prefer. Adherence."},{"key":"10.1016\/j.addr.2022.114133_b0130","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/10647440400003873","article-title":"Usage of antifungal drugs for therapy of genital Candida infections, purchased as over-the-counter products or by prescription: I. Analyses of a unique database","volume":"12","author":"M\u00e5rdh","year":"2004","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114133_b0135","doi-asserted-by":"crossref","unstructured":"R. Palmeira-de-Oliveira, P. Duarte, A. Palmeira-de-Oliveira, J. das Neves, M.H. Amaral, L. Breitenfeld, J. Martinez-de-Oliveira, What do Portuguese Women Prefer Regarding Vaginal Products? Results from a Cross-Sectional Web-Based Survey, Pharmaceutics. 6 (2014) 543\u2013556. Doi: 10.3390\/pharmaceutics6040543.","DOI":"10.3390\/pharmaceutics6040543"},{"key":"10.1016\/j.addr.2022.114133_b0140","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3109\/03639049109048536","article-title":"Preferences of women for use of intravaginal medications","volume":"17","author":"Joglekar","year":"1991","journal-title":"Drug Dev Ind Pharm."},{"key":"10.1016\/j.addr.2022.114133_b0145","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.contraception.2005.12.007","article-title":"Attitudes, perceptions and knowledge about the vagina: the International Vagina Dialogue Survey","volume":"73","author":"Nappi","year":"2006","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/10837450.2017.1339085","article-title":"Vaginal film for prevention of HIV: using visual and tactile evaluations among potential users to inform product design","volume":"23","author":"Guthrie","year":"2018","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.addr.2022.114133_b0155","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.contraception.2015.08.007","article-title":"Meaning-making matters in product design: Users\u2019 sensory perceptions and experience evaluations of long-acting vaginal gels and intravaginal rings","volume":"92","author":"Rosen","year":"2015","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0160","doi-asserted-by":"crossref","DOI":"10.1186\/s12978-018-0494-7","article-title":"Assessing the validity and reliability of self-report data on contraception use in the MObile Technology for Improved Family Planning (MOTIF) randomised controlled trial","volume":"15","author":"Smith","year":"2018","journal-title":"Reprod. Health."},{"key":"10.1016\/j.addr.2022.114133_b0165","article-title":"Women\u2019s experiences with oral and vaginal pre-exposure prophylaxis: The VOICE-C qualitative study in Johannesburg","volume":"9","author":"Van Der Straten","year":"2014","journal-title":"South Africa, PLoS One."},{"key":"10.1016\/j.addr.2022.114133_b0170","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1080\/03630242.2012.728190","article-title":"Mechanistic and \u201cnatural\u201d body metaphors and their effects on attitudes to hormonal contraception","volume":"52","author":"Walker","year":"2012","journal-title":"Women Heal."},{"key":"10.1016\/j.addr.2022.114133_b0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1363\/46E0114","article-title":"Young Women\u2019s contraceptive microbicide preferences: associations with contraceptive behavior and sexual relationship characteristics","volume":"46","author":"Best","year":"2014","journal-title":"Perspect. Sex. Reprod Health."},{"key":"10.1016\/j.addr.2022.114133_b0180","doi-asserted-by":"crossref","unstructured":"T.D.G. do Lago, R.M. Barbosa, S. Kalckmann, W.V. Villela, S. Gohiman, Acceptability of the Diaphragm Among Low-Income Women in Sao Paulo, Brazil, Int. Fam. Plan. Perspect. 21 (1995) 114. Doi: 10.2307\/2133185.","DOI":"10.2307\/2133185"},{"key":"10.1016\/j.addr.2022.114133_b0185","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10461-019-02457-0","article-title":"A mixed-methods study examining adherence to and acceptability of intravaginal rings for HIV prevention: behavioral results of MTN-027","volume":"24","author":"Bauermeister","year":"2020","journal-title":"AIDS Behav."},{"key":"10.1016\/j.addr.2022.114133_b0190","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s10461-020-03026-6","article-title":"Sharing objective measures of adherence to a vaginal microbicide promotes candor about actual use and bolsters motivation to prevent HIV","volume":"25","author":"Kutner","year":"2021","journal-title":"AIDS Behav."},{"key":"10.1016\/j.addr.2022.114133_b0195","article-title":"Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)","volume":"2020","author":"Denison","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.addr.2022.114133_b0200","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3109\/09513590.2010.538095","article-title":"High levels of women\u2019s satisfaction and compliance with transdermal contraception: results from a European multinational, 6-month study","volume":"27","author":"Jakimiuk","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.addr.2022.114133_b0205","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1089\/jwh.2006.0325","article-title":"Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study","volume":"17","author":"Rosen","year":"2008","journal-title":"J Womens Heal."},{"key":"10.1016\/j.addr.2022.114133_b0210","first-page":"1","article-title":"Adherence and acceptability in MTN 001: A randomized crossover trial of daily oral and topical tenofovir for HIV prevention in women","volume":"23","author":"Minnis","year":"2014","journal-title":"AIDS Behav."},{"key":"10.1016\/j.addr.2022.114133_b0215","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.contraception.2007.04.013","article-title":"Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences","volume":"76","author":"Hardy","year":"2007","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0220","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2307\/2133183","article-title":"Acceptability of spermicidal film and foaming tablets among women in three countries","volume":"21","author":"Steiner","year":"1995","journal-title":"Int. Fam. Plan. Perspect."},{"key":"10.1016\/j.addr.2022.114133_b0225","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12905-018-0657-2","article-title":"Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories","volume":"18","author":"Zaveri","year":"2018","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.addr.2022.114133_b0230","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.contraception.2010.11.012","article-title":"Quantitative perceptual differences among over-the-counter vaginal products using a standardized methodology: implications for microbicide development","volume":"84","author":"Mahan","year":"2011","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0235","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1089\/aid.2015.0275","article-title":"Perceptibility and the \u201cchoice experience\u201d: user sensory perceptions and experiences inform vaginal prevention product design","volume":"32","author":"Guthrie","year":"2016","journal-title":"AIDS Res. Hum. Retroviruses."},{"key":"10.1016\/j.addr.2022.114133_b0240","article-title":"Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: Relating user perceptions and experiences to formulation properties","author":"Morrow","year":"2013","journal-title":"AIDS Res Hum Retroviruses."},{"key":"10.1016\/j.addr.2022.114133_b0245","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25528","article-title":"Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment","volume":"23","author":"Minnis","year":"2020","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.addr.2022.114133_b0250","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/QAI.0000000000001945","article-title":"Young women\u2019s stated preferences for biomedical HIV prevention: Results of a discrete choice experiment in Kenya and South Africa","volume":"80","author":"Minnis","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.addr.2022.114133_b0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","article-title":"Constructing experimental designs for discrete-choice experiments: Report of the ISPOR conjoint analysis experimental design good research practices task force","volume":"16","author":"Johnson","year":"2013","journal-title":"Value Heal."},{"key":"10.1016\/j.addr.2022.114133_b0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/hec.1697","article-title":"Discrete choice experiments in health economics: a review of the literature","volume":"21","author":"de Bekker-Grob","year":"2012","journal-title":"Health Econ."},{"key":"10.1016\/j.addr.2022.114133_b0265","doi-asserted-by":"crossref","first-page":"S222","DOI":"10.1097\/QAI.0000000000002215","article-title":"Insights for implementation science from 2 multiphased studies with end-users of potential multipurpose prevention technology and HIV prevention products","volume":"82","author":"Minnis","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.addr.2022.114133_b0270","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/bmj.328.7436.360","article-title":"Discrete choice experiments in health care: NICE should consider using them for patient centred evaluations of technologies","volume":"328","author":"Ryan","year":"2004","journal-title":"BMJ Br. Med. J."},{"key":"10.1016\/j.addr.2022.114133_b0275","doi-asserted-by":"crossref","unstructured":"K.K. Jain, An Overview of Drug Delivery Systems, in: Methods Mol. Biol., Methods Mol Biol, 2020: pp. 1\u201354. Doi: 10.1007\/978-1-4939-9798-5_1.","DOI":"10.1007\/978-1-4939-9798-5_1"},{"key":"10.1016\/j.addr.2022.114133_b0280","doi-asserted-by":"crossref","unstructured":"United Nations, Department of Economic and Social Affairs, Population Division (2019). Contraceptive Use by Method 2019: Data Booklet (ST\/ESA\/SER.A\/435) Available from: http:\/\/digitallibrary.un.org\/record\/3849735.","DOI":"10.18356\/1bd58a10-en"},{"key":"10.1016\/j.addr.2022.114133_b0285","doi-asserted-by":"crossref","first-page":"203","DOI":"10.9745\/GHSP-D-13-00010","article-title":"Use of modern contraception increases when more methods become available: Analysis of evidence from 1982\u20132009","volume":"1","author":"Ross","year":"2013","journal-title":"Glob. Heal. Sci. Pract."},{"key":"10.1016\/j.addr.2022.114133_b0290","doi-asserted-by":"crossref","unstructured":"R.E. Nappi, N.R. de Melo, M. Martino, C. Celis-Gonz\u00e1lez, P. Villaseca, S. R\u00f6hrich, S. Palacios, Vaginal Health: Insights, Views & Attitudes (VIVA-LATAM): results from a survey in Latin America, Doi: 10.1080\/13697137.2018.1461826. 21 (2018) 397\u2013403. Doi: 10.1080\/13697137.2018.1461826.","DOI":"10.1080\/13697137.2018.1461826"},{"key":"10.1016\/j.addr.2022.114133_b0295","doi-asserted-by":"crossref","first-page":"457","DOI":"10.31128\/AJGP-02-19-4851","article-title":"Making choices at menopause","volume":"48","author":"Magraith","year":"2019","journal-title":"Aust. J. Gen. Pract."},{"issue":"2016","key":"10.1016\/j.addr.2022.114133_b0300","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/13697137.2015.1129166","article-title":"IMS Recommendations on womens midlife health and menopause hormone therapy","volume":"19","author":"Baber","year":"2016","journal-title":"Climacteric."},{"key":"10.1016\/j.addr.2022.114133_b0305","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12978-020-0901-8","article-title":"Misoprostol administered sublingually at a dose of 12.5 \u03bcg versus vaginally at a dose of 25 \u03bcg for the induction of full-term labor: A randomized controlled trial","volume":"17","author":"Gatt\u00e1s","year":"2020","journal-title":"Reprod. Health."},{"key":"10.1016\/j.addr.2022.114133_b0310","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.contraception.2006.12.003","article-title":"Treatment satisfaction with a transdermal contraceptive patch or oral contraceptives","volume":"75","author":"Wan","year":"2007","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0315","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2005.01.021","article-title":"Contraceptive efficacy, compliance and beyond: Factors related to satisfaction with once-weekly transdermal compared with oral contraception","volume":"121","author":"Urdl","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.addr.2022.114133_b0320","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaw8145","article-title":"Long-acting reversible contraception by effervescent microneedle patch","volume":"5","author":"Li","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2022.114133_b0325","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijgo.2014.03.012","article-title":"Introduction of postabortion contraception, prioritizing long-acting reversible contraceptives, in the principal maternity hospital of Gabon","volume":"126","author":"Mayi-Tsonga","year":"2014","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.addr.2022.114133_b0330","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1097\/QAD.0000000000001859","article-title":"Preference for injectable over oral HIV pre-exposure prophylaxis in public-sector primary-care clinics in Swaziland","volume":"32","author":"Siedner","year":"2018","journal-title":"Aids."},{"key":"10.1016\/j.addr.2022.114133_b0335","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.contraception.2016.06.006","article-title":"Interest in self-administration of subcutaneous depot medroxyprogesterone acetate in the United States","volume":"94","author":"Upadhyay","year":"2016","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0340","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10461-017-1911-6","article-title":"End-users\u2019 product preference across three multipurpose prevention technology delivery forms: baseline results from young women in Kenya and South Africa","volume":"22","author":"Weinrib","year":"2018","journal-title":"AIDS Behav."},{"key":"10.1016\/j.addr.2022.114133_b0345","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2147\/IJWH.S59059","article-title":"International survey to assess women\u2019s attitudes regarding choice of daily versus nondaily female hormonal contraception","volume":"6","author":"Mansour","year":"2014","journal-title":"Int. J. Women\u2019s Heal."},{"key":"10.1016\/j.addr.2022.114133_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/OAJC.S39690","article-title":"New and emerging contraceptive options: a focus on transdermal contraception","volume":"5","author":"B\u00f6ttcher","year":"2014","journal-title":"Open Access J. Contracept."},{"key":"10.1016\/j.addr.2022.114133_b0355","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2165\/00019053-200422040-00003","article-title":"Development and validation of an acceptability and satisfaction questionnaire for a contraceptive vaginal ring, NuvaRing\u00ae","volume":"22","author":"Nov\u00e1k","year":"2004","journal-title":"Pharmacoeconomics."},{"key":"10.1016\/j.addr.2022.114133_b0360","doi-asserted-by":"crossref","first-page":"182","DOI":"10.9745\/GHSP-D-13-00147","article-title":"Preferences for a potential longer-acting injectable contraceptive: perspectives from women, providers, and policy makers in Kenya and Rwanda","volume":"2","author":"Tolley","year":"2014","journal-title":"Glob. Heal. Sci. Pract."},{"key":"10.1016\/j.addr.2022.114133_b0365","unstructured":"Council of Europe EDQM, European Pharmacopoeia 10.0: Monographs on Dosage Forms, in: EDQM (Ed.), Eur. Pharmacopoeia, 10th ed., Council of Europe, Strasbourg, 2019: p. 903."},{"key":"10.1016\/j.addr.2022.114133_b0370","first-page":"1","article-title":"Acceptability of and treatment preferences for recurrent bacterial vaginosis\u2014Topical lactic acid gel or oral metronidazole antibiotic: Qualitative findings from the VITA trial","volume":"14","author":"Watkins","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114133_b0375","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1363\/3919513","article-title":"Consumer perspectives on a pericoital contraceptive pill in India and Uganda","volume":"39","author":"Cover","year":"2013","journal-title":"Int. Perspect. Sex. Reprod. Health."},{"key":"10.1016\/j.addr.2022.114133_b0380","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.contraception.2013.01.004","article-title":"Interest in a pericoital pill among women in family planning and abortion clinics","volume":"88","author":"Foster","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.addr.2022.114133_b0385","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1089\/jwh.2006.0190","article-title":"Microbicides: information, beliefs, and preferences for insertion","volume":"16","author":"Auslander","year":"2007","journal-title":"J. Women\u2019s Heal."},{"key":"10.1016\/j.addr.2022.114133_b0390","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/108729103322277402","article-title":"Development pharmaceutics of microbicide formulations. Part II: Formulation, evaluation, and challenges","volume":"17","author":"Garg","year":"2003","journal-title":"AIDS Patient Care STDS."},{"key":"10.1016\/j.addr.2022.114133_b0395","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1108524","article-title":"Antiretroviral Prophylaxis for HIV-1 Prevention among Heterosexual Men and Women","volume":"367","author":"Baeten","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2022.114133_b0400","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10461-012-0333-8","article-title":"Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women","volume":"17","author":"Minnis","year":"2013","journal-title":"AIDS Behav."},{"key":"10.1016\/j.addr.2022.114133_b0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241399","article-title":"Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda","volume":"15","author":"Muwonge","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114133_b0410","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3945\/jn.113.188524","article-title":"Tablets are preferred and more acceptable than powdered prenatal calcium supplements among pregnantwomen in Dhaka, Bangladesh","volume":"144","author":"Baxter","year":"2014","journal-title":"J. Nutr."},{"key":"10.1016\/j.addr.2022.114133_b0415","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3945\/jn.109.113498","article-title":"Organoleptic properties, ease of use, and perceived health effects are determinants of acceptability of micronutrient supplements among poor Mexican women","volume":"140","author":"Young","year":"2010","journal-title":"J. Nutr."},{"key":"10.1016\/j.addr.2022.114133_b0420","doi-asserted-by":"crossref","unstructured":"J. das Neves, R. Palmeira-de-Oliveira, A. Palmeira-de-Oliveira, F. Rodrigues, B. Sarmento, Vaginal mucosa and drug delivery, Mucoadhesive Mater. Drug Deliv. Syst. (2014) 99\u2013131.","DOI":"10.1002\/9781118794203.ch05"},{"key":"10.1016\/j.addr.2022.114133_b0425","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","article-title":"Why consider vaginal drug administration?","volume":"82","author":"Alexander","year":"2004","journal-title":"Fertil Steril."},{"key":"10.1016\/j.addr.2022.114133_b0430","first-page":"419","article-title":"Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis","volume":"99","author":"Ferris","year":"2002","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114133_b0435","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/j.1743-6109.2009.01369.x","article-title":"Vaginal dryness: a comparison of prevalence and interventions in 11 countries","volume":"6","author":"Leiblum","year":"2009","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.addr.2022.114133_b0440","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/jsm.12427","article-title":"Women\u2019s use and perceptions of commercial lubricants: prevalence and characteristics in a nationally representative sample of American adults","volume":"11","author":"Herbenick","year":"2014","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.addr.2022.114133_b0445","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1743-6109.2011.02543.x","article-title":"To lube or not to lube: experiences and perceptions of lubricant use in women with and without dyspareunia","volume":"9","author":"Sutton","year":"2012","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.addr.2022.114133_b0450","first-page":"1053","article-title":"Probiotics for the treatment of bacterial vaginosis","volume":"15","author":"Senok","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.addr.2022.114133_b0455","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/clpt.1993.10","article-title":"Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: An international multicenter clinical trial","volume":"53","author":"Coutinho","year":"1993","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.addr.2022.114133_b0460","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2010.04.012","article-title":"Contraceptive vaginal rings: A review","volume":"82","author":"Brache","year":"2010","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0465","doi-asserted-by":"crossref","unstructured":"A. Wilson, ed., Foams: Physics, Chemistry and Structure, (1989). Doi: 10.1007\/978-1-4471-3807-5.","DOI":"10.1007\/978-1-4471-3807-5"},{"key":"10.1016\/j.addr.2022.114133_b0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2010.04.028","article-title":"Foams for pharmaceutical and cosmetic application","volume":"394","author":"Arzhavitina","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114133_b0475","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00003081-197403000-00006","article-title":"Conventional methods of contraception: condom, diaphragm, and vaginal foam","volume":"17","author":"Bernstein","year":"1974","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114133_b0480","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2334-6-90","article-title":"Vaginal microbicides: Detecting toxicities in vivo that paradoxically increase pathogen transmission","volume":"6","author":"Cone","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.addr.2022.114133_b0485","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/10837450.2010.531736","article-title":"Development of sponge-like dressings for mucosal\/transmucosal drug delivery into vaginal cavity","volume":"17","author":"Rossi","year":"2010","journal-title":"Pharm Dev Technol."},{"key":"10.1016\/j.addr.2022.114133_b0490","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0010-7824(02)00434-1","article-title":"Sponge versus diaphragm for contraception: a Cochrane review","volume":"67","author":"Kuyoh","year":"2003","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0495","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1363\/3606404","article-title":"Acceptability of the vaginal diaphragm among current users","volume":"36","author":"Maher","year":"2004","journal-title":"Perspect. Sex. Reprod Health."},{"key":"10.1016\/j.addr.2022.114133_b0500","doi-asserted-by":"crossref","unstructured":"L.A. King, K.A. Michels, B.I. Graubard, B. Trabert, Trends in oral contraceptive and intrauterine device use among reproductive-aged women in the US from 1999 to 2017, Cancer Causes Control. 32 (2021) 587\u2013595. Doi: 10.1007\/s10552-021-01410-8.","DOI":"10.1007\/s10552-021-01410-8"},{"key":"10.1016\/j.addr.2022.114133_b0505","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.contraception.2008.04.118","article-title":"SILCS diaphragm: postcoital testing of a new single-size contraceptive device","volume":"78","author":"Schwartz","year":"2008","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134510","article-title":"Cost-effectiveness of introducing the SILCS diaphragm in South Africa","volume":"10","author":"L\u00e9pine","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114133_b0515","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.contraception.2011.04.003","article-title":"Couples\u2019 acceptability of the SILCS diaphragm for microbicide delivery","volume":"85","author":"Frezieres","year":"2012","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0520","first-page":"CD001500","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","author":"Suckling","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.addr.2022.114133_b0525","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/IJWH.S41897","article-title":"Improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy","volume":"5","author":"Minkin","year":"2013","journal-title":"Int J Womens Heal."},{"key":"10.1016\/j.addr.2022.114133_b0530","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/jwh.2007.0407","article-title":"A retrospective managed care claims data analysis of medication adherence to vaginal estrogen therapy: implications for clinical practice","volume":"17","author":"Shulman","year":"2008","journal-title":"J. Women\u2019s Heal."},{"key":"10.1016\/j.addr.2022.114133_b0535","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/GME.0000000000000729","article-title":"Compliance to vaginal treatment-tablets versus cream: a retrospective 9 years study","volume":"24","author":"Weissmann-Brenner","year":"2017","journal-title":"Menopause."},{"key":"10.1016\/j.addr.2022.114133_b0540","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.maturitas.2012.12.004","article-title":"Women\u2019s preferences toward attributes of local estrogen therapy for the treatment of vaginal atrophy","volume":"74","author":"Mattsson","year":"2013","journal-title":"Maturitas."},{"key":"10.1016\/j.addr.2022.114133_b0545","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0010-7824(99)00060-8","article-title":"Acceptability of two spermicides in five countries","volume":"60","author":"Raymond","year":"1999","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0550","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1089\/jwh.2010.2476","article-title":"Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women","volume":"20","author":"Nel","year":"2011","journal-title":"J. Women\u2019s Heal."},{"key":"10.1016\/j.addr.2022.114133_b0555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jia2.25283","article-title":"End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study","volume":"22","author":"Montgomery","year":"2019","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.addr.2022.114133_b0560","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/jia2.25156","article-title":"FAME-04: A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of film and gel formulations of tenofovir","volume":"21","author":"Bunge","year":"2018","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.addr.2022.114133_b0565","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/QAI.0000000000000897","article-title":"A Phase 1 trial to assess the safety, acceptability, pharmacokinetics and pharmacodynamics of a novel dapivirine vaginal film","volume":"71","author":"Bunge","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.addr.2022.114133_b0570","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s10461-020-02949-4","article-title":"Preferences and acceptability of vaginal delivery forms for hiv prevention among women, male partners and key informants in south africa and zimbabwe: qualitative findings","volume":"25","author":"Musara","year":"2021","journal-title":"AIDS Behav."},{"key":"10.1016\/j.addr.2022.114133_b0575","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000321058","article-title":"Products used on female genital mucosa","volume":"40","author":"Farage","year":"2011","journal-title":"Curr. Probl. Dermatol."},{"key":"10.1016\/j.addr.2022.114133_b0580","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/fampra\/17.2.145","article-title":"Self-medication with vaginal antifungal drugs: physicians\u2019 experiences and women\u2019s utilization patterns","volume":"17","author":"Sihvo","year":"2000","journal-title":"Fam. Pract."},{"key":"10.1016\/j.addr.2022.114133_b0585","doi-asserted-by":"crossref","unstructured":"J. das Neves, M.F. Bahia, Gels as vaginal drug delivery systems, Int J Pharm. 318 (2006) 1\u201314. Doi: S0378-5173(06)00230-4 [pii] 10.1016\/j.ijpharm.2006.03.012.","DOI":"10.1016\/j.ijpharm.2006.03.012"},{"key":"10.1016\/j.addr.2022.114133_b0590","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/13691051003728599","article-title":"Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and India","volume":"12","author":"Greene","year":"2010","journal-title":"Cult. Heal. Sex."},{"key":"10.1016\/j.addr.2022.114133_b0595","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0010-7824(98)00104-8","article-title":"Women\u2019s preferences for vaginal antimicrobial contraceptives. III. Choice of a formulation, applicator, and packaging","volume":"58","author":"Hardy","year":"1998","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0600","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0010-7824(98)00100-0","article-title":"Women\u2019s preferences for vaginal antimicrobial contraceptives. II. Preferred characteristics according to women\u2019s age and socioeconomic status","volume":"58","author":"Hardy","year":"1998","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0605","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00007435-200002000-00011","article-title":"G.r.s. 3rd, Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities","volume":"27","author":"Hammett","year":"2000","journal-title":"Sex Transm Dis."},{"key":"10.1016\/j.addr.2022.114133_b0610","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.addr.2015.02.001","article-title":"Mucoadhesive and thermogelling systems for vaginal drug delivery","volume":"92","author":"Caramella","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114133_b0615","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/jps.20752","article-title":"Temperature and pH sensitive hydrogels: An approach towards smart semen-triggered vaginal microbicidal vehicles","volume":"96","author":"Gupta","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114133_b0620","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0010-7824(02)00430-4","article-title":"Effect of temperature and pH on contraceptive gel viscosity","volume":"67","author":"Owen","year":"2003","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0625","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejps.2017.09.009","article-title":"Vaginal semisolid products: technological performance considering physiologic parameters","volume":"109","author":"Machado","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114133_b0630","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ejpb.2010.07.004","article-title":"Formulation of mucoadhesive vaginal hydrogels insensitive to dilution with vaginal fluids","volume":"76","author":"Aka-Any-Grah","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2022.114133_b0635","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/jps.20386","article-title":"Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen","volume":"94","author":"Geonnotti","year":"2005","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114133_b0640","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2015.04.017","article-title":"Vaginal drug distribution modeling","volume":"92","author":"Katz","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114133_b0645","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.contraception.2006.08.014","article-title":"Optical imaging and analysis of human vaginal coating by drug delivery gels","volume":"75","author":"Henderson","year":"2007","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0650","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.contraception.2012.06.016","article-title":"An exploratory, randomized, crossover MRI study of microbicide delivery with the SILCS diaphragm compared to a vaginal applicator","volume":"87","author":"Pentlicky","year":"2013","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0655","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/jps.23577","article-title":"Vaginal films for drug delivery","volume":"102","author":"Machado","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114133_b0660","unstructured":"Population Council FDA approves the First One-Year Contraceptive Fully under aWoman\u2019s Control, (2018). https:\/\/www.popcouncil.org\/news\/fda-approves-the-first-one-year-contraceptive-fully-under-a-womans-control."},{"key":"10.1016\/j.addr.2022.114133_b0665","unstructured":"Dapivirine Vaginal Ring 25 mg | European Medicines Agency, (2020). https:\/\/www.ema.europa.eu\/en\/opinion-medicine-use-outside-EU\/human\/dapivirine-vaginal-ring-25-mg (accessed October 4, 2021)."},{"key":"10.1016\/j.addr.2022.114133_b0670","unstructured":"WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection, (2021). https:\/\/www.who.int\/news\/item\/26-01-2021-who-recommends-the-dapivirine-vaginal-ring-as-a-new-choice-for-hiv-prevention-for-women-at-substantial-risk-of-hiv-infection (accessed October 4, 2021)."},{"key":"10.1016\/j.addr.2022.114133_b0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224898","article-title":"Vaginal ring acceptability and related preferences among women in low- and middle-income countries: A systematic review and narrative synthesis","volume":"14","author":"Griffin","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114133_b0680","article-title":"Local oestrogen for vaginal atrophy in postmenopausal women","volume":"2016","author":"Lethaby","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.addr.2022.114133_b0685","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/sifp.12046","article-title":"Do women find the progesterone vaginal ring acceptable? Findings from Kenya, Nigeria, and Senegal","volume":"49","author":"RamaRao","year":"2018","journal-title":"Stud. Fam. Plann."},{"key":"10.1016\/j.addr.2022.114133_b0690","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.addr.2016.01.015","article-title":"Microbicide vaginal rings: technological challenges and clinical development","volume":"103","author":"Malcolm","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114133_b0695","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s10508-016-0816-1","article-title":"Preferred physical characteristics of vaginal film microbicides for HIV prevention in Pittsburgh women","volume":"46","author":"Fan","year":"2017","journal-title":"Arch. Sex. Behav."},{"key":"10.1016\/j.addr.2022.114133_b0700","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204821","article-title":"van der Straten, Perceptions of the \u201cFabric\u201d - An exploratory study of a novel multi-purpose technology among women in Sub Saharan Africa","volume":"13","author":"Laborde","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114133_b0705","first-page":"390","article-title":"Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa","volume":"24","author":"Hart","year":"2019","journal-title":"Eur. J. Contracept. Reprod. Heal. Care."},{"key":"10.1016\/j.addr.2022.114133_b0710","first-page":"1","article-title":"User preferences in a carrageenan-based vaginal drug delivery system","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114133_b0715","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.antiviral.2012.12.024","article-title":"Shape of vaginal suppositories affects willingness-to-try and preference","volume":"97","author":"Li","year":"2013","journal-title":"Antiviral Res."},{"key":"10.1016\/j.addr.2022.114133_b0720","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12905-020-01099-y","article-title":"Multiple use applicator for vaginal tablets\/vaginal inserts: compliance verification and suitability studies","volume":"20","author":"Brunner","year":"2020","journal-title":"BMC Womens Health."},{"key":"10.1016\/j.addr.2022.114133_b0725","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1701-2163(15)30682-4","article-title":"Universal vaginal applicator for the uniform distribution of vaginal gel and cream formulations: a magnetic resonance imaging study","volume":"36","author":"Omar","year":"2014","journal-title":"J. Obstet. Gynaecol. Canada."},{"key":"10.1016\/j.addr.2022.114133_b0730","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0002-9378(88)90115-9","article-title":"Patient acceptance of prefilled disposable vaginal applicator","volume":"158","author":"LePage","year":"1988","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114133_b0735","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.olq.0000218877.92778.fe","article-title":"Microbicide applicators: understanding design preferences among women in the Dominican Republic and South Africa","volume":"34","author":"Cohen","year":"2007","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.addr.2022.114133_b0740","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.2105\/AJPH.94.7.1159","article-title":"Acceptability of a microbicide among women and their partners in a 4-country phase I trial","volume":"94","author":"Bentley","year":"2004","journal-title":"Am J Public Heal."},{"key":"10.1016\/j.addr.2022.114133_b0745","doi-asserted-by":"crossref","unstructured":"N. Joglekar, S. Joshi, M. Kakde, G. Fang, M. Cianciola, S. Reynolds, S. Mehendale, T.H.P.T.N. (HPTN) 047 P. TEAM, Acceptability of PRO2000 Vaginal Gel among HIV un-infected Women in Pune, India, Doi: 10.1080\/09540120601133576. 19 (2007) 817\u2013821. Doi: 10.1080\/09540120601133576.","DOI":"10.1080\/09540120601133576"},{"key":"10.1016\/j.addr.2022.114133_b0750","doi-asserted-by":"crossref","unstructured":"M.-M. Tom\u0219a, A.-I. Romon\u021bi-Maniu, M.-A. Scridon, Is Sustainable Consumption Translated into Ethical Consumer Behavior?, Sustain. 2021, Vol. 13, Page 3466. 13 (2021) 3466. Doi: 10.3390\/SU13063466.","DOI":"10.3390\/su13063466"},{"key":"10.1016\/j.addr.2022.114133_b0755","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/jcph.1288","article-title":"An integrated population pharmacokinetic analysis to characterize levonorgestrel pharmacokinetics after different administration routes","volume":"58","author":"Reinecke","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2022.114133_b0760","first-page":"807","article-title":"The intrauterine device and the intrauterine system, Best Pract","volume":"28","author":"Stephen Searle","year":"2014","journal-title":"Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.addr.2022.114133_b0765","doi-asserted-by":"crossref","unstructured":"K.M. Curtis, T.C. Jatlaoui, N.K. Tepper, L.B. Zapata, L.G. Horton, D.J. Jamieson, M.K. Whiteman, U.S. selected practice recommendations for contraceptive use, 2016, MMWR Recomm. Reports. 65 (2016) 1\u201366. Doi: 10.15585\/mmwr.rr6504a1.","DOI":"10.15585\/mmwr.rr6504a1"},{"key":"10.1016\/j.addr.2022.114133_b0770","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.addr.2009.04.022","article-title":"Mirena\u00ae (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception","volume":"61","author":"Rose","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"21","key":"10.1016\/j.addr.2022.114133_b0775","article-title":"Motivations for interest, disinterest and uncertainty in intrauterine device use among young women, matern","volume":"219","author":"Gomez","year":"2017","journal-title":"Child Heal. J."},{"key":"10.1016\/j.addr.2022.114133_b0780","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2147\/PPA.S45710","article-title":"Understanding benefits and addressing misperceptions and barriers to intrauterine device access among populations in the United States","volume":"8","author":"Yoost","year":"2014","journal-title":"Patient Prefer. Adherence."},{"key":"10.1016\/j.addr.2022.114133_b0785","first-page":"29","article-title":"Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study","volume":"19","author":"Short","year":"2014","journal-title":"Eur. J. Contracept. Reprod. Heal. Care."},{"key":"10.1016\/j.addr.2022.114133_b0790","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/13625187.2011.637586","article-title":"The CHOICE study: effect of counselling on the selection of combined hormonal contraceptive methods in 11 countries","volume":"17","author":"Bitzer","year":"2012","journal-title":"Eur. J. Contracept. Reprod. Health Care."},{"key":"10.1016\/j.addr.2022.114133_b0795","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/GRF.0000000000000070","article-title":"The Contraceptive CHOICE Project Round Up: what we did and what we learned","volume":"57","author":"McNicholas","year":"2014","journal-title":"Clin Obs. Gynecol."},{"key":"10.1016\/j.addr.2022.114133_b0800","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.contraception.2011.03.001","article-title":"Acceptance of long-acting reversible contraceptive methods by adolescent participants in the Contraceptive CHOICE Project","volume":"84","author":"Mestad","year":"2011","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0805","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpag.2014.08.002","article-title":"Adolescent and young adult women\u2019s knowledge of and attitudes toward etonogestrel implants","volume":"28","author":"Bachorik","year":"2015","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"10.1016\/j.addr.2022.114133_b0810","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182929","article-title":"Medication eluting devices for the field of OBGYN (MEDOBGYN): 3D printed biodegradable hormone eluting constructs, a proof of concept study","volume":"12","author":"Tappa","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114133_b0815","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217333","article-title":"Potential user interest in new long-acting contraceptives: results from a mixed methods study in Burkina Faso and Uganda","volume":"14","author":"Callahan","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114133_b0820","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/13697137.2018.1439915","article-title":"Menopausal hormone therapy: a better and safer future","volume":"21","author":"Davey","year":"2018","journal-title":"Climacteric."},{"key":"10.1016\/j.addr.2022.114133_b0825","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/13697130400012239","article-title":"Transdermal hormone therapy: Gels and patches","volume":"7","author":"Samsioe","year":"2004","journal-title":"Climacteric."},{"key":"10.1016\/j.addr.2022.114133_b0830","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2147\/IJWH.S102306","article-title":"Transdermal delivery of combined hormonal contraception: a review of the current literature","volume":"9","author":"Galzote","year":"2017","journal-title":"Int. J. Womens. Health."},{"key":"10.1016\/j.addr.2022.114133_b0835","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1701-2163(16)30462-5","article-title":"Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study","volume":"27","author":"Weisberg","year":"2005","journal-title":"J. Obstet. Gynaecol. Canada."},{"key":"10.1016\/j.addr.2022.114133_b0840","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0010-7824(99)00040-2","article-title":"Low dose oral contraceptives and quality of life","volume":"59","author":"Egarter","year":"1999","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0845","first-page":"333","article-title":"Use of short acting reversible contraception in adolescents: the pill, patch, ring and emergency contraception","volume":"48","author":"Saldanha","year":"2018","journal-title":"Curr. Probl. Pediatr. Adolesc. Health Care."},{"key":"10.1016\/j.addr.2022.114133_b0850","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jadohealth.2009.02.007","article-title":"Attitudes toward the vaginal ring and transdermal patch among adolescents and young women","volume":"45","author":"Raine","year":"2009","journal-title":"J. Adolesc. Heal."},{"key":"10.1016\/j.addr.2022.114133_b0855","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/AOG.0b013e31821188ad","article-title":"Continuation and satisfaction of reversible contraception","volume":"117","author":"Peipert","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114133_b0860","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.addr.2021.04.002","article-title":"Microarray patches: Breaking down the barriers to contraceptive care and HIV prevention for women across the globe","volume":"173","author":"Paredes","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114133_b0865","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/B978-1-4160-5583-9.00134-9","article-title":"Contraception","author":"Glasier","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.addr.2022.114133_b0870","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/AOG.0b013e31820ce2f0","article-title":"Long-acting reversible contraceptives: Intrauterine devices and the contraceptive implant","volume":"117","author":"Espey","year":"2011","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.addr.2022.114133_b0875","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/QAI.0000000000001960","article-title":"The invisible product: preferences for sustained-release, long-acting pre-exposure prophylaxis to HIV among South African Youth","volume":"80","author":"Montgomery","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"7","key":"10.1016\/j.addr.2022.114133_b0880","article-title":"Long acting systemic HIV pre-exposure prophylaxis: an examination of the field, Drug Deliv","volume":"76","author":"Lykins","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.addr.2022.114133_b0885","first-page":"191","article-title":"Subcutaneous versus intramuscular depot methoxyprogesterone acetate: a comparative review","volume":"2","author":"Simon","year":"2006","journal-title":"Women\u2019s Heal."},{"key":"10.1016\/j.addr.2022.114133_b0890","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.fertnstert.2016.09.034","article-title":"New developments in long-acting reversible contraception: the promise of intrauterine devices and implants to improve family planning services","volume":"106","author":"Turok","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.addr.2022.114133_b0895","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s13643-018-0827-1","article-title":"Evidence of patients\u2019 challenges and barriers related to usage of Implanon\u00ae: scoping review protocol","volume":"7","author":"Prosad","year":"2018","journal-title":"Syst. Rev."},{"key":"10.1016\/j.addr.2022.114133_b0900","unstructured":"U. Nations, United Nations Sustainable Development Goals, (n.d.). https:\/\/unfoundation.org\/what-we-do\/issues\/sustainable-development-goals\/?gclid=CjwKCAjw2P-KBhByEiwADBYWCoz5dTSr7QMlz_9EGUp9TLVzdkmHT5uyikGN3NALOkS4_m6_F7GHbhoCJlIQAvD_BwE (accessed September 27, 2021)."},{"key":"10.1016\/j.addr.2022.114133_b0905","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0022-4731(79)90066-9","article-title":"Biodegradable systems for the sustained release of fertility-regulating agents","volume":"11","author":"Benagiano","year":"1979","journal-title":"J. Steroid Biochem."},{"key":"10.1016\/j.addr.2022.114133_b0910","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10461-019-02576-8","article-title":"Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms","volume":"24","author":"Weinrib","year":"2020","journal-title":"AIDS Behav."},{"key":"10.1016\/j.addr.2022.114133_b0915","doi-asserted-by":"crossref","unstructured":"E.A. Krogstad, M. Atujuna, E.T. Montgomery, A. Minnis, S. Ndwayana, T. Malapane, M.K. Shapley-Quinn, K. Manenzhe, L.-G. Bekker, A. van der Straten, Perspectives of South African youth in the development of an implant for HIV prevention., J. Int. AIDS Soc. 21 (2018) e25170. Doi: 10.1002\/jia2.25170.","DOI":"10.1002\/jia2.25170"},{"key":"10.1016\/j.addr.2022.114133_b0920","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/01.olq.0000243619.51895.bd","article-title":"Measurement of microbicide acceptability among U.S. adolescent girls","volume":"34","author":"Short","year":"2007","journal-title":"Sex. Transm. Dis."},{"issue":"43","key":"10.1016\/j.addr.2022.114133_b0925","article-title":"User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides","volume":"437","author":"Morrow","year":"2014","journal-title":"Arch. Sex. Behav."},{"key":"10.1016\/j.addr.2022.114133_b0930","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0010-7824(98)00100-0","article-title":"Women\u2019s preferences for vaginal antimicrobial contraceptives II: Preferred characteristics according to women\u2019s age and socioeconomic status","volume":"58","author":"Hardy","year":"1998","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0935","doi-asserted-by":"crossref","unstructured":"A.L. Corneli, J. Deese, M. Wang, D. Taylor, K. Ahmed, K. Agot, J. Lombaard, R. Manongi, S. Kapiga, A. Kashuba, L. Van Damme, W. Agingu, J. Ambia, J. Asewe, I. De Baetselier, S. Chetty-Tulsee, S. Chiduo, T. Crucitti, K. Fransen, J.G. Gaddiel, H. Kiernan, S. Kirkendale, T. Lalbahadur, M. Lanham, T. Lucky, P. Mak\u2019Oketch, S. Makatu, M. Malahleha, J. Mandala, M. Mankalimeng, M. Masaki, T. Mastro, K. McKenna, M.C. Monedi, S. Mullins, K. Nanda, J. Odhiambo, I. Olango, P. Omullo, Z. Omungo, F. Owino, C. Parker, M. Ratlhagana, I. Reblin, L. Saylor, P. Siguntu, J.S. Skhosana, A. Troxler, V. Veena, L. Venkatasubramanian, G. Venter, C. Wong, FEM-PrEP: Adherence patterns and factors associated with adherence to a daily oral study product for pre-exposure prophylaxis, J. Acquir. Immune Defic. Syndr. 66 (2014) 324\u2013331. Doi: 10.1097\/QAI.0000000000000158.","DOI":"10.1097\/QAI.0000000000000158"},{"key":"10.1016\/j.addr.2022.114133_b0940","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1089\/jwh.2006.15.952","article-title":"Adolescents\u2019 descriptions of the physical characteristics of microbicide surrogates and experiences of use","volume":"15","author":"Zubowicz","year":"2006","journal-title":"J. Women\u2019s Heal."},{"key":"10.1016\/j.addr.2022.114133_b0945","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25626","article-title":"An open-label, randomized crossover study to evaluate the acceptability and preference for contraceptive options in female adolescents, 15 to 19 years of age in Cape Town, as a proxy for HIV prevention methods (UChoose)","volume":"23","author":"Gill","year":"2020","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.addr.2022.114133_b0950","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jpag.2020.06.022","article-title":"Best practices for counseling adolescents about the etonogestrel implant","volume":"33","author":"Berlan","year":"2020","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"10.1016\/j.addr.2022.114133_b0955","doi-asserted-by":"crossref","unstructured":"ACOG Committee Opinion No. 735: Adolescents and Long-Acting Reversible Contraception: Implants and Intrauterine Devices, Obstet. Gynecol. 131 (2018) e130\u2013e139. Doi: 10.1097\/AOG.0000000000002632.","DOI":"10.1097\/AOG.0000000000002632"},{"key":"10.1016\/j.addr.2022.114133_b0960","first-page":"298","article-title":"Determinants of long-acting reversible contraceptive (LARC) use by adolescent girls and young women","volume":"17","author":"Bharadwaj","year":"2012","journal-title":"Eur. J. Contracept. Reprod. Heal. Care."},{"key":"10.1016\/j.addr.2022.114133_b0965","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/2150131916641095","article-title":"Knowledge and acceptability of long-acting reversible contraception among adolescent women receiving school-based primary care services","volume":"7","author":"Hoopes","year":"2016","journal-title":"J. Prim. Care Community Health."},{"key":"10.1016\/j.addr.2022.114133_b0970","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jpag.2011.02.003","article-title":"Acceptability of the vaginal contraceptive ring among adolescent women","volume":"24","author":"Terrell","year":"2011","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"key":"10.1016\/j.addr.2022.114133_b0975","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.contraception.2011.02.007","article-title":"Factors associated with uptake of subdermal contraceptive implants in a young Kenyan population","volume":"84","author":"Hubacher","year":"2011","journal-title":"Contraception."},{"key":"10.1016\/j.addr.2022.114133_b0980","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1089\/jwh.2008.0886","article-title":"Health practices and vaginal microbicide acceptability among urban black women","volume":"17","author":"Reiff","year":"2008","journal-title":"J. Women\u2019s Heal."},{"key":"10.1016\/j.addr.2022.114133_b0985","first-page":"1","article-title":"Variations in microbicide gel acceptability among young women in the USA and Puerto Rico","volume":"23","author":"Giguere","year":"2013","journal-title":"Cult Heal. Sex."},{"key":"10.1016\/j.addr.2022.114133_b0990","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/sti.2003.005934","article-title":"Acceptability of COL-1492, a vaginal gel, among sex workers in one Asian and three African cities","volume":"80","author":"Vandebosch","year":"2004","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.addr.2022.114133_b0995","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2307\/2950824","article-title":"Preferences for contraceptive attributes: voices of Women in Ciudad Ju\u00e1rez, Mexico","volume":"23","author":"Garcia","year":"1997","journal-title":"Int. Fam. Plan. Perspect."},{"key":"10.1016\/j.addr.2022.114133_b1000","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/13691058.2010.507876","article-title":"Intravaginal insertion in KwaZulu-Natal: sexual practices and preferences in the context of microbicide gel use","volume":"12","author":"Gafos","year":"2010","journal-title":"Cult. Heal. Sex."},{"key":"10.1016\/j.addr.2022.114133_b1005","first-page":"CD004695","article-title":"Continuous or extended cycle vs. cyclic use of combined hormonal contraceptives for contraception","author":"Edelman","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.addr.2022.114133_b1010","doi-asserted-by":"crossref","unstructured":"R. Paul, B.C. Huysman, R. Maddipati, T. Madden, Familiarity and acceptability of long-acting reversible contraception and contraceptive choice, Am. J. Obstet. Gynecol. 222 (2020) S884.e1\u2013S884.e9. Doi: 10.1016\/j.ajog.2019.11.1266.","DOI":"10.1016\/j.ajog.2019.11.1266"},{"key":"10.1016\/j.addr.2022.114133_b1015","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10461-017-1913-4","article-title":"A randomized crossover study evaluating the use and acceptability of the SILCS diaphragm compared to vaginal applicators for vaginal gel delivery","volume":"22","author":"Beksinska","year":"2018","journal-title":"AIDS Behav."},{"key":"10.1016\/j.addr.2022.114133_b1020","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1369-7625.2007.00441.x","article-title":"Do people want to be autonomous patients? Preferred roles in treatment decision-making in several patient populations","volume":"10","author":"Deber","year":"2007","journal-title":"Health Expect."},{"key":"10.1016\/j.addr.2022.114133_b1025","doi-asserted-by":"crossref","unstructured":"K.B. Guzzo, S.R. Hayford, Adolescent Reproductive and Contraceptive Knowledge and Attitudes and Adult Contraceptive Behavior, Matern. Child Heal. J. 2017 221. 22 (2017) 32\u201340. Doi: 10.1007\/S10995-017-2351-7.","DOI":"10.1007\/s10995-017-2351-7"},{"issue":"21","key":"10.1016\/j.addr.2022.114133_b1030","article-title":"The use of ACOG guidelines: perceived contraindications to IUD and implant use among family planning providers","volume":"219","author":"Philliber","year":"2017","journal-title":"Matern. Child Heal. J."},{"key":"10.1016\/j.addr.2022.114133_b1035","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.nurpra.2019.05.005","article-title":"Beliefs and use of intrauterine devices (IUDs) among Women\u2019s health care providers","volume":"15","author":"Esposito","year":"2019","journal-title":"J. Nurse Pract."},{"key":"10.1016\/j.addr.2022.114133_b1040","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/03630242.2019.1616042","article-title":"Patients and providers\u2019 knowledge, attitudes, and beliefs regarding immediate postpartum long-acting reversible contraception: a systematic review","volume":"60","author":"Thompson","year":"2020","journal-title":"Women Heal."},{"key":"10.1016\/j.addr.2022.114133_b1045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10461-017-1977-1","article-title":"Impact of the dapivirine vaginal ring on sexual experiences and intimate partnerships of women in an HIV prevention clinical trial: managing ring detection and hot sex","volume":"22","author":"Laborde","year":"2018","journal-title":"AIDS Behav."},{"issue":"16","key":"10.1016\/j.addr.2022.114133_b1050","article-title":"High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in african women","volume":"167","author":"van der Straten","year":"2012","journal-title":"AIDS Behav."},{"key":"10.1016\/j.addr.2022.114133_b1055","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1592\/phco.28.6.712","article-title":"Absorption, bioavailability, and partner transfer of estradiol from a topical emulsion","volume":"28","author":"Taylor","year":"2008","journal-title":"Pharmacother. J. Hum. Pharmacol Drug Ther."},{"key":"10.1016\/j.addr.2022.114133_b1060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1472-6874-12-40","article-title":"An assessment of the likely acceptability of vaginal microbicides for HIV prevention among women in rural Ghana","volume":"12","author":"Abdulai","year":"2012","journal-title":"BMC Womens Health."},{"key":"10.1016\/j.addr.2022.114133_b1065","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/QAI.0000000000002463","article-title":"Prevention, partners, and power imbalances: women\u2019s views on how male partners AFFECTED their adherence to vaginal microbicide gels during HIV prevention Trials in Africa","volume":"85","author":"Miller","year":"2020","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.addr.2022.114133_b1070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226062","article-title":"Perceptions of and interest in HIV pre-exposure prophylaxis use among adolescent girls and young women in Lilongwe, Malawi","volume":"15","author":"Maseko","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114133_b1075","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.contraception.2019.01.002","article-title":"Shared negative experiences of long-acting reversible contraception and their influence on contraceptive decision-making: a multi-methods study","volume":"99","author":"Brown","year":"2019","journal-title":"Contraception."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X22000230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X22000230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:21:37Z","timestamp":1759209697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X22000230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":215,"alternative-id":["S0169409X22000230"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2022.114133","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Women\u2019s preferences and acceptance for different drug delivery routes and products","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2022.114133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114133"}}